InvestorsObserver
×
News Home

Should You Buy Titan Pharmaceuticals, Inc. common stock (TTNP) Stock on Wednesday?

Wednesday, February 10, 2021 01:07 PM | InvestorsObserver Analysts

Mentioned in this article

Should You Buy Titan Pharmaceuticals, Inc. common stock (TTNP) Stock on Wednesday?

Titan Pharmaceuticals, Inc. common stock (TTNP) stock has gained 19.41% over the past week and gets a Bullish rating from InvestorsObserver's Sentiment Indicator.

Sentiment Score - ,bullish
Titan Pharmaceuticals, Inc. common stock has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on TTNP!

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment.

Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor.

InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon.

The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With TTNP Stock Today?

Titan Pharmaceuticals, Inc. common stock (TTNP) stock is trading at $4.06 as of 1:04 PM on Wednesday, Feb 10, a loss of -$0.17, or -4.02% from the previous closing price of $4.23. The stock has traded between $3.68 and $4.29 so far today. Volume today is 1,872,425 compared to average volume of 1,997,576.

To screen for more stocks like Titan Pharmaceuticals, Inc. common stock click here.

More About Titan Pharmaceuticals, Inc. common stock

Titan Pharmaceuticals Inc is a specialty pharmaceutical company. It is engaged in the development and commercialization of pharmaceutical products. The company product pipeline consists of Probuphine for Opioid addiction, Ropinirole for Parkinson's disease, Triiodothyronine (T3) for hypothyroidism. It generates revenue principally from collaborative research and development arrangements, technology licenses, and government grants.

Click Here to get the full Stock Score Report on Titan Pharmaceuticals, Inc. common stock (TTNP) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App